{"name": "Foldrx Pharmaceuticals", "permalink": "foldrx-pharmaceuticals", "crunchbase_url": "http://www.crunchbase.com/company/foldrx-pharmaceuticals", "homepage_url": "http://www.foldrx.com/", "blog_url": "", "blog_feed_url": "", "twitter_username": "", "category_code": "biotech", "number_of_employees": null, "founded_year": 2003, "founded_month": null, "founded_day": null, "deadpooled_year": null, "deadpooled_month": null, "deadpooled_day": null, "deadpooled_url": null, "tag_list": "", "alias_list": "", "email_address": "info@foldrx.com", "phone_number": "617-252-5500", "description": "", "created_at": "Wed Jun 16 14:01:56 UTC 2010", "updated_at": "Wed Jun 16 14:01:55 UTC 2010", "overview": "\u003Cp\u003EFoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The company\u00d0\u00a2s pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson\u0026#8217;s disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.\u003C/p\u003E", "image": null, "products":  [], "relationships":  [{"is_past": false,    "title": "President and CEO",    "person":     {"first_name": "Richard",      "last_name": "Labaudini\u00c3\u00a8re",      "permalink": "richard-labaudinire"}}], "competitions":  [], "providerships":  [], "total_money_raised": "$29M", "funding_rounds":  [{"round_code": "unattributed",    "source_url": "http://www.fiercebiotech.com/story/foldrx-banks-29m-neurodegenerative-drug-application/2010-06-15?utm_medium=rss\u0026utm_source=rss",    "source_description": "FoldRx banks $29M for neurodegenerative drug application",    "raised_amount": 29000000.0,    "raised_currency_code": "USD",    "funded_year": 2010,    "funded_month": 6,    "funded_day": 15,    "investments":     [{"company": null,       "financial_org":        {"name": "Novo Ventures",         "permalink": "novo-ventures"},       "person": null},      {"company": null,       "financial_org":        {"name": "Morgenthaler Ventures",         "permalink": "morgenthaler-ventures"},       "person": null},      {"company": null,       "financial_org":        {"name": "HealthCare Ventures",         "permalink": "healthcare-ventures"},       "person": null},      {"company": null,       "financial_org":        {"name": "Fidelity Biosciences",         "permalink": "fidelity-biosciences-2"},       "person": null},      {"company": null,       "financial_org":        {"name": "TPG Biotechnology Partners",         "permalink": "tpg-biotechnology-partners"},       "person": null},      {"company": null,       "financial_org":        {"name": "Alta Partners",         "permalink": "alta-partners"},       "person": null},      {"company": null,       "financial_org":        {"name": "Novartis Venture Funds",         "permalink": "novartis-ventures"},       "person": null}]}], "investments":  [], "acquisition":  {"price_amount": null,   "price_currency_code": "USD",   "term_code": null,   "source_url": "http://www.foldrx.com/e4df4c77-5824-4ea5-94b7-aede5d74e4f5/news-press-detail.htm",   "source_description": "Pfizer To Acquire FoldRx Pharmaceuticals",   "acquired_year": 2010,   "acquired_month": 9,   "acquired_day": 1,   "acquiring_company":    {"name": "Pfizer",     "permalink": "pfizer"}}, "acquisitions":  [], "offices":  [{"description": "",    "address1": "100 Acorn Park Drive",    "address2": "5th Floor",    "zip_code": "02140",    "city": "Cambridge",    "state_code": "MA",    "country_code": "USA",    "latitude": null,    "longitude": null}], "milestones":  [], "ipo": null, "video_embeds":  [], "screenshots":  [], "external_links":  []}